UMR is a coalition of leading research institutions, patient and health advocates and private industry seeking steady and sustainable increases in funding for the National Institutes of Health (NIH) in order to save and improve lives, advance innovation and fuel the economy.
In this episode of The Amazing Things Podcast, we talk to Dr. Lucie Low about tissue chip technology and its potential to change how we develop and test new drugs. Dr. Low is the Scientific Program Manager of the Tissue Chip for Drug Screening Program at the National Center for Advancing Translational Sciences (NCATS), part of the National Institute of Health.
View episode
